Skip Navigation LinksHome > February 2014 - Volume 30 - Issue 2 > Infant Botulism and Indications for Administration of Botuli...
Pediatric Emergency Care:
doi: 10.1097/PEC.0000000000000079
CME Review Article

Infant Botulism and Indications for Administration of Botulism Immune Globulin

Pifko, Elysha MD; Price, Amanda MD; Sterner, Sarah MD, FAAP, FACEP

Continued Medical Education
Collapse Box

Abstract

Abstract: Infant botulism is caused by the ingestion of Clostridium botulinum spores and leads to a life-threatening descending motor weakness and flaccid paralysis in infant children. This disease presents with symptoms such as constipation, weakness, and hypotonia and can lead to respiratory failure. Botulism immune globulin (BIG) was created to treat this deadly disease and functions by neutralizing all systemically circulating botulism toxins. It is indicated in children with clinically diagnosed infant botulism, before diagnostic confirmation, and has been shown to lead to a significant reduction in intensive care unit and hospital stay for these patients. This review article discusses the epidemiology, clinical presentation, history of BIG, and indications for administration of BIG.

© 2014 Lippincott Williams & Wilkins, Inc.

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.